drugset
Drugs / Preforpro
last change Jun 2025 re-read 3 minutes ago

Preforpro

Other / unclassified

Developed for
bacterial vaginosis
Investigated by
Deerland Enzymes · Jeremy Burton · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · St. Joseph's Health Care London

Trials 1

today NCT05590195 · Ph 3
20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05590195 May 2024 → Mar 2025 bacterial vaginosis Jeremy Burton Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PreforPro “Effect of PreforPro® (Prebiotic and Bacteriophage) on Urinary and Vaginal Health” NCT05590195 ↗
1

NCT05590195 ↗
Modality Other / unclassified “PreforPro® (Prebiotic and bacteriophages” NCT05590195 ↗
Route Oral “participants will consume one capsule per day” NCT05590195 ↗